Fulgent Genetics (FLGT) Long-Term Investments (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Long-Term Investments for 10 consecutive years, with $369.3 million as the latest value for Q4 2025.
- Quarterly Long-Term Investments fell 35.26% to $369.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $369.3 million through Dec 2025, down 35.26% year-over-year, with the annual reading at $369.3 million for FY2025, 35.26% down from the prior year.
- Long-Term Investments hit $369.3 million in Q4 2025 for Fulgent Genetics, down from $411.8 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $602.2 million in Q3 2024 to a low of $287.6 million in Q1 2021.
- Historically, Long-Term Investments has averaged $435.8 million across 5 years, with a median of $413.7 million in 2022.
- Biggest five-year swings in Long-Term Investments: surged 25025.48% in 2021 and later crashed 35.26% in 2025.
- Year by year, Long-Term Investments stood at $485.0 million in 2021, then crashed by 32.66% to $326.6 million in 2022, then rose by 29.67% to $423.6 million in 2023, then skyrocketed by 34.65% to $570.4 million in 2024, then plummeted by 35.26% to $369.3 million in 2025.
- Business Quant data shows Long-Term Investments for FLGT at $369.3 million in Q4 2025, $411.8 million in Q3 2025, and $484.5 million in Q2 2025.